Thermal Ablation Treats Some Lung Cancer
Posted on: Monday, 17 July 2006, 18:00 CDT
Fifty-seven percent of U.S. lung cancer patients with early-stage, I-II, non-small cell lung cancer treated with thermal ablation lived up to three years.
During thermal ablation, an interventional radiologist uses imaging to guide a small needle through the skin into the tumor. Energy is then transmitted to the tip of the needle to cook and kill the tumor with heat or freeze it with cold.
Only one-third of patients diagnosed with non-small cell lung cancer are eligible for surgery -- the rest face the reality of having less than 12 months to live, states study author Dr. Damian Dupuy, of Rhode Island Hospital, in Providence.
These new outpatient treatments not only are effective, but allow us to treat patients who historically have no other options. Utilizing imaging and targeted thermal ablation, we can heat and destroy lung tumors, and extend a patients life. As a physician, it's so gratifying to be able to provide a treatment that is so beneficial to patients and so easy for them to undergo.
The findings are published in the Journal of Vascular and Interventional Radiology.
Source: United Press International
Related Articles
- NeoPharm Enrolls First Patient in Phase I Trial for Patients With Metastatic Solid Cancer
- Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
- Biomira Initiates Phase 1 Trial of PX-478 in Patients With Advanced Metastatic Cancers
- New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients With Non-Small Cell Lung Cancer
- NYU Medical Center Partners With Rosetta Genomics to Develop a Line of Diagnostic Tools for Lung and Mesothelioma Cancers
- AVAX Technologies Announces the Initiation of Its Clinical Study for the Treatment of Patients With Non Small Cell Lung Cancer
- Human Genome Sciences Reports Results of Phase 2 Clinical Trial of HGS-ETR1 In Patients With Advanced Colorectal Cancer
- Comparison of Different Methods for Delineation of ^Sup 18^F-FDG PET- Positive Tissue for Target Volume Definition in Radiotherapy of Patients With Non-Small Cell Lung Cancer
- The Role of Whole-Body Bone Scanning and Clinical Factors in Detecting Bone Metastases in Patients With Non-Small Cell Lung Cancer*
- Patients Large and Small: Role of the Pharmacist in Veterinary Medicine
User Comments (0)

RSS Feeds